Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 05-2011 | 03-2011 | 02-2011 | 12-2010 | |
| Operating Expenses | 350 | 592 | 300 | 647 | 590 |
| Operating Income | -350 | -592 | -300 | -647 | -590 |
| Interest Expense | 0 | 7 | 0 | 3 | 3 |
| Other Income | 1,050 | 1,056 | 8 | 8 | -7 |
| Pre-tax Income | 700 | 457 | -292 | -643 | -600 |
| Net Income Continuous | 450 | 457 | -640 | -643 | -600 |
| Net Income | $450 | $457 | $-640 | $-643 | $-600 |
| EPS Basic Total Ops | N/A | 0.01 | N/A | -0.01 | N/A |
| EPS Basic Continuous Ops | N/A | 0.01 | N/A | -0.01 | N/A |
| EPS Diluted Total Ops | N/A | 0.01 | N/A | -0.01 | N/A |
| EPS Diluted Continuous Ops | N/A | 0.01 | N/A | -0.01 | N/A |
| EBITDA(a) | $-333 | $-575 | $-290 | $-641 | $-590 |